We manufacture and bring patients across North America, MENA and Europe a broad range of 800+ pharmaceutical injectable, oral generics, branded generics, specialty and compounded products.
Our large manufacturing facilites in the US supply generic and speciality products to the United States and Canadia markets across a broad range of therapeutic areas, including respiratory, oncology and pain management. We sell branded generics and in-licensed patented products across the Middle Easst and North Africa (MENA) with manufacturing facilities in six MENA countries, and our injectable manufacturing facilities in Portugal, Italy and Germany have a range of capabilities including dedicated capacity for oncology and cephalosporins. These facilities supply injectable products to North America, MENA and a growing number of markets in Europe. Our products are approved in different countries for specific uses and the information we provide is governed by local laws and regulations.
Please visit our local Hikma websites to find out more about our products in your country of residence. Always ask a healthcare professional for advice about medicines.
Please report a potential adverse event by submitting an online form
Explore more
Number of products as of February 2025